Access to anti-retroviral drugs, female in Belize
Belize: Access to anti-retroviral drugs, female was 51.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Belize, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Belize stood at 51.0%. That is the highest value across all 25 years on record.
That represents a change of up 4.1% on the previous year and up 41.7% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Belize peaked at 51.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Belize 118th out of 141 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Belize, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 2.0% | — |
| 2003 | 6.0% | +200.0% |
| 2004 | 5.0% | -16.7% |
| 2005 | 9.0% | +80.0% |
| 2006 | 11.0% | +22.2% |
| 2007 | 14.0% | +27.3% |
| 2008 | 18.0% | +28.6% |
| 2009 | 26.0% | +44.4% |
| 2010 | 28.0% | +7.7% |
| 2011 | 34.0% | +21.4% |
| 2012 | 34.0% | +0.0% |
| 2013 | 36.0% | +5.9% |
| 2014 | 36.0% | +0.0% |
| 2015 | 39.0% | +8.3% |
| 2016 | 41.0% | +5.1% |
| 2017 | 42.0% | +2.4% |
| 2018 | 44.0% | +4.8% |
| 2019 | 45.0% | +2.3% |
| 2020 | 45.0% | +0.0% |
| 2021 | 46.0% | +2.2% |
| 2022 | 48.0% | +4.3% |
| 2023 | 49.0% | +2.1% |
| 2024 | 51.0% | +4.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 9.1% | 0.0% | 26.0% | 10 |
| 2010s | 37.9% | 28.0% | 45.0% | 10 |
| 2020s | 47.8% | 45.0% | 51.0% | 5 |
Countries ranked near Belize
- 116 Armenia 52.0% compare
- 116 Libya 52.0% compare
- 118 Ghana 51.0% compare
- 118 Papua New Guinea 51.0% compare
- 118 South Sudan 51.0% compare
More gender data for Belize
- Child population (UN estimates and projections) 110.84 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4356 % change on previous year (2030)
- Age population, age 00, female, interpolated 3,647 (2025)
- Age population, age 00, male, interpolated 3,832 (2025)
- Age population, age 01, female, interpolated 3,619 (2025)
- Age population, age 01, male, interpolated 3,802 (2025)
- Age population, age 02, female, interpolated 3,506 (2025)
- Age population, age 02, male, interpolated 3,683 (2025)
- Age population, age 03, female, interpolated 3,305 (2025)
- Age population, age 03, male, interpolated 3,470 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Belize?
- Access to anti-retroviral drugs, female in Belize was 51.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Belize?
- The highest recorded value was 51.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Belize?
- The lowest recorded value was 0.0% in 2000.
- How does Belize rank for access to anti-retroviral drugs, female?
- Belize ranks 118th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Belize?
- Over the last ten years it is up 41.7%. The long-run trend across the full record is volatile.
- Where does this Belize data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.